Informações:
Falhas:
ID
29138
Descrição
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control; ODM derived from: https://clinicaltrials.gov/show/NCT00701831
Link
https://clinicaltrials.gov/show/NCT00701831
Palavras-chave
Versões (1)
- 28/02/2018 28/02/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
28 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 2 NCT00701831
Eligibility Diabetes Mellitus, Type 2 NCT00701831
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00701831
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Insulin naive
Item
t2 insulin naïve patients
boolean
C0011860 (UMLS CUI [1])
C0021641 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0021641 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
Lantus Initiation considering
Item
patients whom their physician is considering initiation of lantus treatment
boolean
C0876064 (UMLS CUI [1,1])
C1704686 (UMLS CUI [1,2])
C0750591 (UMLS CUI [1,3])
C1704686 (UMLS CUI [1,2])
C0750591 (UMLS CUI [1,3])
Poor glycemic control Percentage
Item
poor glycemic control 7,5 %10 %
boolean
C0342299 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Therapeutic procedure Non-Insulin-Dependent Diabetes Mellitus | Antidiabetics Oral
Item
t2 treatment with oads more than 3 months
boolean
C0087111 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0011860 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
Body mass index
Item
bmi<40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Renal Insufficiency | Creatinine measurement, serum | Dialysis
Item
impaired renal function (cr>2mg/dl or current renal dialysis)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
Metabolic acidosis | Chronic metabolic acidosis
Item
acute or chronic metabolic acidosis
boolean
C0220981 (UMLS CUI [1])
C0740749 (UMLS CUI [2])
C0740749 (UMLS CUI [2])
Liver disease | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
active liver disease or serum alt or ast >2,5 than normal
boolean
C0023895 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
Loss of hypoglycemic warning
Item
history of hypoglycemia unawareness
boolean
C0342317 (UMLS CUI [1])
Diabetic Retinopathy | Operative Surgical Procedures | Operative Surgical Procedures Planned
Item
diabetic retinopathy with surgery in the previous 3 months or planned within 3 months after study entry
boolean
C0011884 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0543467 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0543467 (UMLS CUI [2])
C0543467 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnancy, breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Aspect Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1,1])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])